|
ANKS1A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.53669965641257E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.35810000046722E-07 |
| Normal-vs-Stage2 |
5.59079999962186E-07 |
| Normal-vs-Stage3 |
3.75389996865039E-09 |
| Normal-vs-Stage4 |
2.1910000003178E-07 |
| Stage1-vs-Stage2 |
4.740400E-01 |
| Stage1-vs-Stage3 |
1.548580E-01 |
| Stage1-vs-Stage4 |
1.340990E-01 |
| Stage2-vs-Stage3 |
5.655800E-01 |
| Stage2-vs-Stage4 |
3.923200E-01 |
| Stage3-vs-Stage4 |
6.562400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48160381133289E-11 |
| Normal-vs-AfricanAmerican |
1.017710E-02 |
| Normal-vs-Asian |
3.15136805539851E-12 |
| Caucasian-vs-AfricanAmerican |
3.155800E-01 |
| Caucasian-vs-Asian |
9.969600E-04 |
| AfricanAmerican-vs-Asian |
1.681680E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.10338429901458E-12 |
| Normal-vs-Female |
5.419200E-03 |
| Male-vs-Female |
2.454200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.481510E-02 |
| Normal-vs-Extreme_Weight |
2.69784194983913E-14 |
| Normal-vs-Obese |
1.50279999999725E-07 |
| Normal-vs-Extreme_Obese |
2.13439999999787E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.676000E-01 |
| Normal_Weight-vs-Obese |
9.979400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.454600E-01 |
| Extreme_Weight-vs-Obese |
1.039660E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.670200E-01 |
| Obese-vs-Extreme_Obese |
5.441600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.774170E-01 |
| Normal-vs-Age(41-60Yrs) |
5.38429967278375E-10 |
| Normal-vs-Age(61-80Yrs) |
7.65750000075727E-08 |
| Normal-vs-Age(81-100Yrs) |
9.18749520906204E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.848200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.090600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.907920E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.107400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.438820E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.499400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.4266144649232E-12 |
| Normal-VS-Type2 PRCC |
7.85482789922298E-13 |
| Normal-VS-KIRP CIMP |
2.336600E-01 |
| Normal-VS-Unclassified PRCC |
1.696690E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.982000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.103600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.181800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.340200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.748200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.636800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.99986726967927E-12 |
| Normal-vs-N1 |
1.620650E-03 |
| Normal-vs-N2 |
1.69789999999725E-05 |
| N0-vs-N1 |
1.198820E-01 |
| N0-vs-N2 |
6.278000E-01 |
| N1-vs-N2 |
3.254600E-01 |
|
|
